Ijichi K - Search Results

1

Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells.

Adachi M, Ijichi K, Hasegawa Y, Nakamura H, Ogawa T, Kanematsu N. Adachi M, et al. Among authors: ijichi k. Exp Ther Med. 2010 Jan;1(1):93-96. doi: 10.3892/etm_00000017. Epub 2010 Jan 1. Exp Ther Med. 2010. PMID: 23136600 Free PMC article.

2

Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells.

Furuse S, Adachi M, Ijichi K, Ohta S, Torigoe S, Nakazawa M, Miura S, Mitsudo K, Tohnai I. Furuse S, et al. Among authors: ijichi k. Oncol Rep. 2010 May;23(5):1339-43. doi: 10.3892/or_00000769. Oncol Rep. 2010. PMID: 20372849

3

Hypersensitivity to cisplatin after hRev3 mRNA knockdown in head and neck squamous cell carcinoma cells.

Adachi M, Ijichi K, Hasegawa Y, Ogawa T, Nakamura H, Yasui Y, Fukushima M, Ishizaki K. Adachi M, et al. Among authors: ijichi k. Mol Med Rep. 2008 Sep-Oct;1(5):695-8. doi: 10.3892/mmr_00000015. Mol Med Rep. 2008. PMID: 21479472

4

Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.

Murata S, Adachi M, Kioi M, Torigoe S, Ijichi K, Hasegawa Y, Ogawa T, Bhayani MK, Lai SY, Mitsudo K, Tohnai I. Murata S, et al. Among authors: ijichi k. Anticancer Res. 2011 Sep;31(9):2893-8. Anticancer Res. 2011. PMID: 21868535

5

Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma.

Maseki S, Ijichi K, Nakanishi H, Hasegawa Y, Ogawa T, Murakami S. Maseki S, et al. Among authors: ijichi k. Mol Clin Oncol. 2013 Sep;1(5):918-924. doi: 10.3892/mco.2013.159. Epub 2013 Jul 24. Mol Clin Oncol. 2013. PMID: 24649271 Free PMC article.

6

Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.

Ijichi K, Adachi M, Ogawa T, Hasegawa Y, Murakami S. Ijichi K, et al. Anticancer Res. 2014 Jun;34(6):2907-11. Anticancer Res. 2014. PMID: 24922653

7

Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.

Hasegawa Y, Goto M, Hanai N, Ijichi K, Terada A, Hyodo I, Ogawa T, Fukushima M. Hasegawa Y, et al. Among authors: ijichi k. Oncology. 2007;73(1-2):104-11. doi: 10.1159/000120998. Epub 2008 Mar 13. Oncology. 2007. PMID: 18337622

8

Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.

Ijichi K, Adachi M, Hasegawa Y, Ogawa T, Nakamura H, Kudoh A, Yasui Y, Murakami S, Ishizaki K. Ijichi K, et al. Cancer Chemother Pharmacol. 2008 Oct;62(5):745-52. doi: 10.1007/s00280-007-0658-6. Epub 2007 Dec 13. Cancer Chemother Pharmacol. 2008. PMID: 18075740

9

Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.

Hasegawa Y, Goto M, Hanai N, Ijichi K, Adachi M, Terada A, Hyodo I, Ogawa T, Furukawa T. Hasegawa Y, et al. Among authors: ijichi k. Oral Oncol. 2007 Sep;43(8):749-56. doi: 10.1016/j.oraloncology.2006.09.003. Epub 2006 Nov 16. Oral Oncol. 2007. PMID: 17112769

10

A peripheral primitive neuroectodermal tumor in the larynx: A case report and literature review.

Ijichi K, Tsuzuki T, Adachi M, Murakami S. Ijichi K, et al. Oncol Lett. 2016 Feb;11(2):1120-1124. doi: 10.3892/ol.2015.4013. Epub 2015 Dec 9. Oncol Lett. 2016. PMID: 26893703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters